Chief Business Officer Audet Juliette Berangere was granted 14,000 units of Ordinary Shares, increasing direct ownership by 1,268% to 15,104 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

NAMS· NewAmsterdam Pharma Company N.V.

Health Care

Original source

Chief Business Officer Audet Juliette Berangere was granted 14,000 units of Ordinary Shares, increasing direct ownership by 1,268% to 15,104 units (SEC Form 4) | Quantisnow